Suven Life Sciences gets two product patents

21 Jun 2011 Evaluate

Suven Life Sciences has received two product patents, one from Europe and the other from New Zealand. These grants were received for the New Chemical Entities (NCE) for the treatment of neurodegenerative disease. These patents are valid till 2027 and 2025. With the two new patents, Suven now has a total of ten granted patents in Europe and 11 in New Zealand.crackcrack

Suven Life Sciences Share Price

170.15 -1.25 (-0.73%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×